It's been amazing to see the progress in generative AI mAb design, by both our team and others (Chai, Germinal, etc)
Excited to announce mBER, our fully open AI tool for de novo design of epitope-specific antibodies. To validate, we ran the largest de novo antibody experiment to date: >1M designs tested against 145 targets, measuring >100M interactions. We found specific binders for nearly half the targets, with up to 40% hit rates. Thread below:View quoted post on X